Safety and Tolerability of SH-1028 in Patients With Advanced Solid Cancer
Clinical trial NCT03618043 · UNKNOWN
Trial details
- NCT number
- NCT03618043
- Sponsor
- Nanjing Sanhome Pharmaceutical, Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-13
- Primary completion
- 2019-12-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.